Question 32: Did the recipient receive concomitant therapy?
Concomitant therapy is given to enhance the function of the cellular therapy. In cases where a recipient has both HCT and cell therapy, this question applies to the cell therapy infusion, not the HCT. If the recipient had a prior HCT and the therapy was already captured on the HCT form as being HCT prep regimen, it is not reported again. See question 33 for a list of drugs that can be given as concomitant therapy.
Question 33-34: Specify drugs:
Select the drug(s) given as concomitant therapy. If the drug given is not in the list, check Other and specify the drug in question 34.
Question 35: Specify time point:
Concomitant therapy can be given simultaneously with the cellular therapy infusion or up to 24 hours after infusion (post cell therapy).
|Question Number||Date of Change||Add/Remove/Modify||Description||Reasoning (If applicable)|
Need more help with this?
Don’t hesitate to contact us here.